Skip to main content
Douglas Drossman, MD, Gastroenterology, Durham, NC, University of North Carolina Hospitals

DouglasADrossmanMD

Gastroenterology • Durham, NC

President Drossman Center for Education and Practice of Biopsychosocial Care LLC and Drossman Gastroenterology PLLC; Co-Director Emeritus UNC Center for Functional GI and Motility Disorders; CEO and President Emeritus, Rome Foundation

Join to view full profile

Dr. Drossman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Drossman's full profile

Already have an account?

Summary

  • I am a board certified gastroenterologist with joint training in psychiatry (psychosomatic medicine) focusing on brain-gut interactions in research, teaching and patient care. Throughout my professional career I have been committed to improving patient care within my practice of Gastroenterology, with training in communication skills (to improve the patient-doctor relationship) and research and educational expertise in mind-body illnesses and brain gut interactions. I have served in many roles at the University of North Carolina (UNC) Medical Center and elsewhere (CV and biosketch available). I have been a leader and organizer of several organizations, founder and now president of the Rome Foundation, founder and former head of the Functional Brain-Gut Research Group of the American Gastroenterology Association as well as founder and co-director of the UNC Center for Functional GI and Motility Disorders. I was a charter fellow of the American Academy of Communication in HealthCare, and was on the Board of Directors and Scientific Chair of the International Foundation for Functional GI Disorders, a patient advocacy group. I have received over $15 million in research grants and have presented the research through peer reviewed scholarly publications and at international scientific fora. For decades my clinical practice has attracted referrals of patients with the most complex and difficult to diagnose and treat functional GI disorders. I have used modern methods to educate physicians in these skills through on-site preceptorships, interactive video presentations, training workshops, digitally-based programs, and I have also educated patients through books and articles, news media and TV shows. These experiences have irrevocably led to my recent decision to focus on teaching clinicians to improve their dialog with patients in order to help reverse the failing healthcare system. Thus I have formed a specialty practice and an educational program as below.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina Hospitals1978
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1975 - 1976
  • University of Rochester Medical Center
    University of Rochester Medical Center1976
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1972
  • University of North Carolina Hospitals
    University of North Carolina HospitalsInternship, Internal Medicine, 1970 - 1971
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1970

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1976 - 2025
  • TX State Medical License
    TX State Medical License 1974 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • David Sun Award American College of Gastroenterology, 2012
  • American Journal of Gastroenterology Award American College of Gastroenterology, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Patients and Doctors Will Understand Those “Gut Feelings” After Reading This Sequel
    Patients and Doctors Will Understand Those “Gut Feelings” After Reading This SequelJune 7th, 2022
  • The Rome Foundation Translates Clinical Diagnostic Criteria
    The Rome Foundation Translates Clinical Diagnostic CriteriaDecember 3rd, 2021
  • Rome Foundation Releases Clinical Criteria to Better Meet Needs of Patients
    Rome Foundation Releases Clinical Criteria to Better Meet Needs of PatientsNovember 29th, 2021
  • Join now to see all

Grant Support

  • Prevalence Of EGG Abnormalities In The Functional GI DisordersNational Center For Research Resources2007–2008
  • Effect Of Low Carbohydrate Diet On Symptoms Of IBS: A Prospective Pilot StudyNational Center For Research Resources2007–2008
  • Dexloxiglumide 200 MG Tid In Female Patients With Constipation-Predom IBSNational Center For Research Resources2004
  • SB 207266 A W/Placebo In Treatment Of Irritable Bowel SyndromeNational Center For Research Resources1999–2002
  • Long Term Use Of Alosetron In Subjects W/ Irritable Bowel SyndromeNational Center For Research Resources1999–2002
  • Clinical Trial Of OPC 12759 For Treatment Of NON Ulcer DyspepsiaNational Center For Research Resources1999–2002
  • Alosetron In Female Subjects W/ Irritable Bowel SyndromeNational Center For Research Resources1999–2002
  • Alosetron For Anxiety In Females W/ Irritable Bowel SyndromeNational Center For Research Resources1999–2002
  • Study Of Controlled Release Darifenacine In Treatment Of IBSNational Center For Research Resources1998–2002
  • Multicenter Trial Of Functional Bowel DisordersNational Center For Research Resources1997–2002
  • Multicenter Trial Of Functional Bowel DisordersNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2001
  • Sb-207266-A In Irritable Bowel Syndrome W/ HIV InfectionNational Center For Research Resources2000
  • Cilansetron In Non-Constipated PTS W/ Irritable Bowel SyndromeNational Center For Research Resources2000
  • Alosetron In Subjects With Non-Ulcer DyspepsiaNational Center For Research Resources2000
  • Sb-277266-A Placebo In Patients With Irritable Bowel SyndromeNational Center For Research Resources1997–1999
  • Double Blind Placebo Controlled Study Of Fedotozine In Irritable Bowel SyndromeNational Center For Research Resources1997–1999
  • Comparison Of Librax And Its Components On Psychosocial Function In IBSNational Center For Research Resources1995
  • Abuse/Psychosocial Factors In Patients With Gastrointestinal DisordersNational Center For Research Resources1995
  • Abuse/Psychosocial Factors In Patients With GI DisordersNational Institute Of Mental Health1991–1994
  • Irritable Bowel Syndrome: Characterizing The PatientNational Institute Of Diabetes And Digestive And Kidney Diseases1987
  • Irritable Bowel Syndrome Characterizing The PatientNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Professional Memberships

Hospital Affiliations

Dr. Douglas Drossman, Dr. Douglas Drossman, MD, Dr. D Drossman, Dr. Douglas A Drossman